Skip Navigation



Home » Drug Information » FDA Approved Drugs » 1996
Medical Areas: Musculoskeletal | Neurology | Oncology | Family Medicine

View By:YearCompanyConditionsTherapeutic AreasDrug Names


The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Purepac Pharmaceutical
Approval Status: Approved July 1996
Treatment Area: chronic pain

General Information

Kadian, a single daily dosage sustained-release morphine product, has been approved by the FDA. Kadian provides relief for chronic moderate to severe pain (pain related to cancer), and has been demonstrated to be as effective when taken once a day as conventional morphine products taken every four hours.